Oncology Market Access Strategy Summit
February 20th-21st
This was TikaMobile’s first year in attendance of the 12th Annual Oncology Market Access Strategy Summit.
San Francisco, California
PharmaTimes: News RSS
- Researchers say hydroxychloroquine could still prevent COVID-19
- EU approves new indication for Novartis’ Xolair
- Second COVID-19 peak in the UK can be avoided with testing and tracing, study finds
- GSK’s anti-BCMA drug Blenrep wins US approval
- AZ’s Fasenra study confirms robust efficacy in eosinophilic asthma
- UCB’s Cimzia bags EU label extension
- NICE updates guidance on chronic pain treatments
- Novavax’s COVID-19 vaccine produces immune response in early study
- Novartis’ CAR-T therapy Kymriah hits endpoint in follicular lymphoma trial
- Pharma’s reputation has climbed during COVID-19 pandemic, study finds
English
Arabic
Chinese (Simplified)
Dutch
English
French
German
Italian
Portuguese
Russian
Spanish